Molecular parameters associated with insulinoma progression: chromosomal instability versus p53 and CK19 status-Reference-Cited by-同舟云学术

Molecular parameters associated with insulinoma progression: chromosomal instability versus p53 and CK19 status

Published:2006 Issue:3-4 Volume:115 Page:289-297
ISSN:1424-8581
Container-title:Cytogenetic and Genome Research
language:en
Short-container-title:Cytogenet Genome Res

Author:

Jonkers Y.M.H.,Claessen S.M.H.,Veltman J.A.,Geurts van Kessel A.,Dinjens W.N.M.,Skogseid B.,Ramaekers F.C.S.,Speel E.-J.M.

Publisher

S. Karger AG

Subject

Genetics (clinical),Genetics,Molecular Biology

Reference35 articles.

1. Albarello L, Capitanio V, Zerbi A, Di Carlo V, Doglioni C: Cytokeratin 19 expression in pancreatic endocrine tumors. J Pancreas 6 (5 suppl):514 (2004).

2. p53 tumour suppressor gene expression in pancreatic neuroendocrine tumour cells.

3. Cytokeratins and cell differentiation in the pancreas

4. Losses of Chromosomes 1p and 3q Are Early Genetic Events in the Development of Sporadic Pheochromocytomas

5. Deshpande V, Fernandez-del Castillo C, Muzikansky A, Deshpande A, Zukerberg L, etal: Cytokeratin 19 is a powerfull predictor of survival in pancreatic endocrine tumors. Am J Surg Pathol 28:1145-1153 (2004).

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aggressive versus indolent insulinomas: new clinicopathological insights;Endocrine-Related Cancer;2023-02-13

2. An Insight on Functioning Pancreatic Neuroendocrine Neoplasms;Biomedicines;2023-01-21

3. Malignant insulinoma: Can we predict the long-term outcomes?;World Journal of Clinical Cases;2022-06-06

4. Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors;Endocrine Pathology;2021-01-18

5. Transcriptomic analysis by RNA sequencing characterises malignant progression of canine insulinoma from normal tissue to metastatic disease;Scientific Reports;2020-07-14